ByHeart Broadens Voluntary Recall While Investigation Continues fdagov

The U.S. Food and Drug Administration cleared for marketing the first in vitro diagnostic device that tests blood, to aid in diagnosing Alzheimer’s disease.

The U.S. Department of Health and Human Services and FDA today announced a series of new measures to phase out all petroleum-based synthetic dyes from the nation’s food supply—a significant…

FDA approved a new drug to treat S. aureus bloodstream infections; acute bacterial skin & skin structure infections; and community-acquired bacterial pneumonia.